Matthew Cohen

ORCID: 0000-0001-9087-2678
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • COVID-19 Clinical Research Studies
  • COVID-19 and healthcare impacts
  • Global Public Health Policies and Epidemiology
  • Long-Term Effects of COVID-19
  • Global Health Care Issues
  • Liver Disease Diagnosis and Treatment
  • Diabetes Management and Education
  • Urinary Tract Infections Management
  • Machine Learning in Bioinformatics
  • Lung Cancer Treatments and Mutations
  • Venous Thromboembolism Diagnosis and Management
  • Pediatric Urology and Nephrology Studies
  • RNA modifications and cancer
  • Non-Invasive Vital Sign Monitoring
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Urinary Bladder and Prostate Research
  • Global Cancer Incidence and Screening
  • Respiratory Support and Mechanisms
  • Global Maternal and Child Health
  • Lung Cancer Diagnosis and Treatment
  • Pharmaceutical Economics and Policy
  • Pharmaceutical studies and practices
  • Health Systems, Economic Evaluations, Quality of Life
  • Thermal Regulation in Medicine
  • Healthcare Systems and Reforms

Columbia University
2020-2021

Columbia University Irving Medical Center
2021

Council on Foreign Relations
2017-2019

To characterize patients with coronavirus disease 2019 (covid-19) in a large New York City medical center and describe their clinical course across the emergency department, hospital wards, intensive care units.Retrospective manual record review.NewYork-Presbyterian/Columbia University Irving Medical Center, quaternary academic City.The first 1000 consecutive positive result on reverse transcriptase polymerase chain reaction assay for severe acute respiratory syndrome 2 (SARS-CoV-2) who...

10.1136/bmj.m1996 article EN cc-by-nc BMJ 2020-05-29

Demographic and epidemiological changes are shifting the disease burden from communicable to noncommunicable diseases in lower-income countries. Within a generation, share of attributed some poor countries will exceed 80 percent, rivaling that rich countries, but this is likely affect much younger people poorer The health systems unprepared for change. We examined shift estimated preparedness by ranking 172 nations using system capacity index disease. project with greatest increases...

10.1377/hlthaff.2017.0708 article EN cc-by Health Affairs 2017-11-01

Previous analyses of democracy and population health have focused on broad measures, such as life expectancy at birth child infant mortality, shown some contradictory results. We used a panel data spanning 170 countries to assess the association between cause-specific mortality explore pathways connecting democratic rule gains.We extracted HIV-free estimates from Global Burden Diseases, Injuries, Risk Factors Study 2016 information regime type Varieties Democracy project. These cover 46...

10.1016/s0140-6736(19)30235-1 article EN cc-by The Lancet 2019-03-14

Abstract Objective To characterize patients with coronavirus disease 2019 (COVID-19) in a large New York City (NYC) medical center and describe their clinical course across the emergency department (ED), inpatient wards, intensive care units (ICUs). Design Retrospective manual record review. Setting NewYork-Presbyterian/Columbia University Irving Medical Center (NYP/CUIMC), quaternary academic NYC. Participants The first 1000 consecutive laboratory-confirmed COVID-19. Methods We identified...

10.1101/2020.04.20.20072116 preprint EN cc-by-nc-nd medRxiv (Cold Spring Harbor Laboratory) 2020-04-22

To evaluate whether off-patent prescription drugs at risk of sudden price increases or shortages in the United States are available from independent manufacturers approved other well regulated settings around world.Observational study.Off-patent USA and by Food Drug Administration, up to 10 April 2017.Novel tablet capsule FDA since 1939 that were no longer protected patents market exclusivity had three generic versions.Number additional obtained approval any seven non-US regulators with...

10.1136/bmj.k831 article EN cc-by-nc BMJ 2018-03-19

The phenomenon of silent hypoxaemia has been described in patients with COVID-19 pneumonia, which is characterised by low oxygen saturation levels <90% those who appear clinically well and do not show signs significant respiratory distress. To assess the impact on clinical outcomes for high-risk using a pulse oximeter to monitor home setting. We performed retrospective cohort analysis data from large South African insurance administrator. Patients were categorised as high risk, based age...

10.7196/samj.2021.v111i10.15880 article EN South African Medical Journal 2021-09-03

Coronavirus disease 2019 (COVID-19) may predispose patients to venous thromboembolism (VTE). Limited data are available on the utilization of Pulmonary Embolism Response Team (PERT) in setting COVID-19 global pandemic. We performed a single-center study evaluate treatment, mortality, and bleeding outcomes who received PERT consultations March April 2020, compared historical controls from same period 2019. Clinical were abstracted electronic medical record. The primary endpoints inpatient...

10.1177/1358863x21995896 article EN cc-by Vascular Medicine 2021-04-04

Lung cancer is the most common cause of deaths worldwide, accounting for 1.8 million each year. Only 20% lung cases are reported to occur in low- and middle-income countries. An estimated 1.5% all Ethiopian cancers involved lung; however, no nationwide registry exists Ethiopia. Thus, accurate data on clinical history, histopathology, molecular characteristics, risk factors not available. The aim this study was describe clinical, radiologic, pathologic including available profiles, at Tikur...

10.1016/j.jtocrr.2021.100196 article EN cc-by-nc-nd JTO Clinical and Research Reports 2021-05-31
Coming Soon ...